Related Experiment Video
Updated: Jul 14, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Development and characterization of a recombinant cDNA-based hepatitis C virus system.
Jean Ndjomou1, Ying Liu, John O'Malley
1Department of Microbiology and Immunology, Indiana University School of Medicine, R2 302, 950 W. Walnut Street, Indianapolis, IN 46202, USA.
Biochemical and Biophysical Research Communications
|May 29, 2007
Summary
Researchers developed a new Hepatitis C virus (HCV) system for studying viral replication and developing therapeutics. This system facilitates research despite the genotype-specific limitations of current methods.
Area of Science:
- Virology
- Molecular Biology
- Hepatology
Background:
- Subgenomic Hepatitis C virus (HCV) replicons and in vitro production systems have advanced HCV research.
- Current in vitro systems are limited by genotype-specific dependencies, hindering broad research applications.
Purpose of the Study:
- To develop a novel recombinant DNA-based HCV system for studying viral replication and assembly.
- To overcome genotype-specific limitations in current HCV in vitro models.
Main Methods:
- Constructed a recombinant DNA-based HCV genotype 1b system with EF-1alpha promoter, replacing E1/E2 with GFP.
- Co-transfected 293T cells with the recombinant cDNA and HCV E1/E2 or VSV-G expression plasmids.
Main Results:
- Demonstrated expression and processing of HCV proteins in co-transfected cells.
- Confirmed the production of Hepatitis C virus-like particles (VLPs) in the culture supernatant.
Conclusions:
- The developed system shows potential for studying HCV polyprotein expression, processing, and VLP assembly and release.
- This novel system may aid in the screening of anti-HCV therapeutics and understanding the HCV life cycle.
